n-3 polyunsaturated fatty acids alleviate the progression of obesity-related osteoarthritis and protect cartilage through inhibiting the HMGB1-RAGE/TLR4 signaling pathway
International Immunopharmacology · 2024-02 · 128 · 111498
DOI: 10.1016/j.intimp.2024.111498 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024-02. Verfasst von Tao Xiong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Environmental Stress and Chronic Disease Control & Prevention (China Medical University), Ministry of Education, Shenyang, Liaoning…. Hauptthemen laut MEDLINE: Fatty Acids, Omega-3, HMGB1 Protein, Osteoarthritis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Department of Education of Liaoning Province, Scientific Research Fund of Liaoning Provincial Education Department.
Abstract (Originalsprache)
Osteoarthritis (OA) is a common joint degenerative disease. There is currently no cure for OA. Dietary fatty acids have potential value in the prevention and treatment of OA. n-3 polyunsaturated fatty acids (PUFAs) have anti-inflammatory effects, but their anti-OA mechanism remains unclear. High-mobility group box 1 (HMGB1) promotes inflammation and participates the pathogenesis of OA. The purpose of this study was to investigate the protective effect of n-3 PUFAs on cartilage and whether n-3 PUFAs could exert an anti-OA effect through inhibiting HMGB1-RAGE/TLR4 signaling pathway. We established an obesity-related post-traumatic OA mice model and an in vitro study was conducted to explore the regulatory mechanism of n-3 PUFAs on HMGB1 and its signal pathway against OA. We found that diet rich in n-3 PUFAs alleviated OA-like lesions of articular cartilage with the decrease of HMGB1-RAGE/TLR4 signaling protein in mice. In SW1353 cells, DHA significantly reduced the expression of HMGB1-RAGE/TLR4 signaling protein which was up-regulated by IL-1β stimulation. HMGB1 overexpression reversed the inhibitory effect of DHA on HMGB1-RAGE/TLR4 signaling pathway. The activation of SIRT1 may participate the inhibitory effect of DHA on HMGB1-RAGE/TLR4 signaling pathway. In conclusion, n-3 PUFAs could attenuate the progression of obesity-related OA and exert protective effect on cartilage by inhibiting HMGB1-RAGE/TLR4 signaling pathway, which may be associated with the activation of SIRT1. Dietary n-3 PUFAs supplements can be considered as a potential therapeutic substance for OA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Environmental Stress and Chronic Disease Control & Prevention (China Medical University), Ministry of Education, Shenyang, Liaoning 110122, PR China; Department of Nutrition and Food Hygiene, School of…
- Department of Orthopedics, Shengjing Hospital, China Medical University, 110004, PR China. Electronic address: guhailun_@163.com.
Förderung
- National Natural Science Foundation of China
- Department of Education of Liaoning Province
- Scientific Research Fund of Liaoning Provincial Education Department
Zitieren
APA
Xiong, T., Huang, S., Wang, X., Shi, Y., He, J., Yuan, Y., Wang, R., Gu, H., & Liu, L. (2024). n-3 polyunsaturated fatty acids alleviate the progression of obesity-related osteoarthritis and protect cartilage through inhibiting the HMGB1-RAGE/TLR4 signaling pathway. International Immunopharmacology, 128, 111498. https://doi.org/10.1016/j.intimp.2024.111498
Vancouver
Xiong T, Huang S, Wang X, Shi Y, He J, Yuan Y, et al. n-3 polyunsaturated fatty acids alleviate the progression of obesity-related osteoarthritis and protect cartilage through inhibiting the HMGB1-RAGE/TLR4 signaling pathway. International Immunopharmacology. 2024;128:111498. doi:10.1016/j.intimp.2024.111498
BibTeX
@article{Xiong2024,
author = {Xiong, Tao and Huang, Shiqi and Wang, Xinjuan and Shi, Yu and He, Jianyi and Yuan, Ye and Wang, Ruiqi and Gu, Hailun and Liu, Li},
title = {n-3 polyunsaturated fatty acids alleviate the progression of obesity-related osteoarthritis and protect cartilage through inhibiting the HMGB1-RAGE/TLR4 signaling pathway},
journal = {International Immunopharmacology},
year = {2024},
volume = {128},
pages = {111498},
doi = {10.1016/j.intimp.2024.111498}
}
EUVIMED